Glonghui December 20 | Walterdyne (000915.SZ) said on the investor interactive platform on December 20 that in recent years, sales of pediatric ibuprofen suppositories have been in line with expectations, and the growth rate has been relatively good. The rapid growth of pediatric ibuprofen suppositories has had a positive impact on the company's annual performance growth, but since it previously accounted for a relatively small share of the company's drug sales, the impact is not significant at this stage.
华特达因(000915.SZ)：小儿布洛芬栓的快速增长对公司全年业绩增长有积极的影响
Walterdyne (000915.SZ): The rapid growth of pediatric ibuprofen suppositories had a positive impact on the company's annual performance growth
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.